Logo-apb
Adv Pharm Bull. 2022;12(2): 237-247. doi: 10.34172/apb.2022.025
PMID: 35620334        PMCID: PMC9106955

Review Article

Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes

Hadi Rajabi 1 ORCID, Mahdi Ahmadi 2, Somayeh Aslani 3, Shirin Saberianpour 4, Reza Rahbarghazi 5,6 * ORCID

Cited by CrossRef: 1


1- Jia Y, Li D, Yu J, Jiang W, Liao X, Zhao Q. Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review. Front Cardiovasc Med. 2022;9 [Crossref]